NHS Logo

Management of the Breast and Axilla in the Neoadjuvant Setting (Record no. 101763)

MARC details
000 -LEADER
fixed length control field 05071nam a22004695i 4500
001 - CONTROL NUMBER
control field 978-3-030-88020-0
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729134612.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 211214s2022 sz | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
ISBN 9783030880200
-- 978-3-030-88020-0
072 #7 - SUBJECT CATEGORY CODE
Subject category code MN
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MN
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED085000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MN
Source thema
072 #7 - SUBJECT CATEGORY CODE
Subject category code MN
Source thema
245 10 - TITLE STATEMENT
Title Management of the Breast and Axilla in the Neoadjuvant Setting
250 ## - EDITION
Edition statement 1st ed. 2022.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Cham :
Name of producer, publisher, distributor, manufacturer Springer International Publishing :
-- Imprint: Springer,
Date of production, publication, distribution, manufacture, or copyright notice 2022.
300 ## - PHYSICAL DESCRIPTION
Physical description XI, 377 p. 152 illus., 80 illus. in color.
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
505 0# - CONTENTS
Contents Evolution of the indications for neoadjuvant systemic therapy -- Defining response -- Imaging of the breast -- Imaging of the axilla and approach to node-negative vs. node-positive disease at presentation -- Guidelines for imaging during neoadjuvant systemic therapy -- Neoadjuvant systemic therapy based on the underlying tumor biology -- Adjuvant vs. neoadjuvant systemic therapy -- Molecular testing and personalized neoadjuvant treatment -- Pre-and post-neoadjuvant systemic therapy imaging assessment -- Surgical management of the axilla in node-negative and node-positive disease at diagnosis -- Surgical considerations and expectations in patients receiving neoadjuvant hormonal therapy and neoadjuvant chemotherapy -- Postmastectomy radiation considerations in patients receiving neoadjuvant chemotherapy -- Pathologic evaluation in neoadjuvant systemic therapy setting -- Guidelines for Neoadjuvant systemic therapy -- Ongoing Clinical studies and future direction.
520 ## - ABSTRACT
Abstract Over the last several decades breast cancer management has made great strides in the improvement of oncologic treatment outcomes, particularly so in patients with early stage disease. While wide-spread access to screening resulting in early detection is undoubtedly to be credited for this trend, at the same time, the management of breast cancer has evolved to be an intricate multidisciplinary collaboration between breast imagers, surgeons, medical oncologists and radiation oncologist. As a result, with better mutual understanding of multidisplinary goals and challenges, the treatment strategies have become more individualized, with a great emphasis being placed on the intrinsic disease biology. Furthermore, the indications for neoadjuvant systemic therapy have significantly broadened, with a substantial number of patients with early stage breast cancer being able to take advantage of this strategy to decrease the extent of breast surgery they would undergo at its completion. As such, the management of the axilla in these patients has presented with new challenges as well as with new opportunities to scale down on the extent of local therapy and, consequently, its toxicity. This text will provide a comprehensive, state-of-the art review of this field, and will serve as a valuable resource for clinicians (surgeons, medical oncologists, radiation oncologists) and researchers with an interest in breast cancer. The book will review novel and evoling strategies in neoadjuvant systemic therapy forn early stage breast cancer, provide new perspectives about appropriate axillary imaging in anticipation of neoadjuvant systemic therapy, and describe new data on innovative surgical techniques and Radiation Oncology concepts designed to deescalate the extent and toxicity of local therapy while insuring oncologic safety. Several landmark clinical trials have been published in the last few years and will be placed in context with respect to current management. Integration of novel diagnostic and interventional breast imaging, local therapy (surgery and radiation) with contemporary systemic therapy will also be discussed. This text will serve as a very useful resource for physicians and researchers dealing with, and interested in, this challenging field. It will provide a concise yet comprehensive summary of the current status of the field that will help guide patient management and stimulate investigative efforts. All chapters will be written by experts in their fields and will include the most up to date scientific and clinical information.
650 #0 - SUBJECT HEADINGS
Subject term Surgery.
650 #0 - SUBJECT HEADINGS
Subject term Internal medicine.
9 (RLIN) 6654
650 14 - SUBJECT HEADINGS
Subject term Surgery.
650 24 - SUBJECT HEADINGS
Subject term Surgery.
650 24 - SUBJECT HEADINGS
Subject term Internal Medicine.
9 (RLIN) 6654
700 1# - ADDED PERSONAL NAME
Added personal author Soran, Atilla.
Relator term editor.
700 1# - ADDED PERSONAL NAME
Added personal author Nakhlis, Faina.
Relator term editor.
710 2# - ADDED CORPORATE NAME
Added corporate author SpringerLink (Online service)
856 ## - ONLINE RESOURCE
Uniform Resource Identifier <a href="#gotoholdings">#gotoholdings</a>
Link text Access resource
245 ## - TITLE STATEMENT
Medium [E-Book]
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
912 ## -
-- ZDB-2-SME
912 ## -
-- ZDB-2-SXM
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Date last seen Uniform Resource Identifier Price effective from Koha item type
        Hillingdon Hospitals Library Services (Hillingdon Hospitals NHS Foundation) Hillingdon Hospitals Library Services (Hillingdon Hospitals NHS Foundation) Online 02/05/2024 Springer BiomedLifeSc   02/05/2024 https://go.openathens.net/redirector/nhs?url=https://doi.org/10.1007/978-3-030-88020-0 02/05/2024 Electronic book
London Health Libraries Consortium Privacy notice and Membership terms and conditions